BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Opsona Therapeutics Ltd. 

The O'Reilly Institute
Trinity College Dublin
Dublin    2  Ireland
Phone: n/a Fax: 353-1-679-8039


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Opsona Therapeutics Ltd. Raises an Additional $4 Million Series C From Omnes Capital 10/2/2013 7:10:30 AM
Opsona Therapeutics Ltd. Initiates a Phase II Study With OPN-305, a First-in Class Monoclonal Antibody That Blocks Toll-Like Receptor 2, in Renal Transplant Patients at High Risk of Delayed Graft Function 5/7/2013 11:19:59 AM
Opsona Therapeutics Ltd. Raises $43 Million to Develop Lead Product 4/29/2013 6:56:26 AM
Opsona Therapeutics Ltd. Announces the Issuance of New Patent From the European Patent Office (EPO) Covering the Development and Use of an Antibody Directed Against Toll-like Receptor TLR-2 4/17/2012 10:24:23 AM
Opsona Therapeutics Ltd. Adds 3.3 Million Euro to Series B 5/20/2009 8:13:04 AM
Galapagos NV (GLPG.BR) And Opsona Therapeutics Ltd. Initiate Drug Discovery Collaboration 4/21/2009 12:11:23 PM
Opsona Therapeutics Ltd., CSL Limited (CMXHF.PK) Form Vaccine Adjuvant R&D Collaboration Targeting Infectious Diseases And Oncology 2/23/2009 11:59:18 AM
Opsona Therapeutics Ltd. Closes E18 Million Funding 2/18/2009 7:06:23 AM
Opsona Therapeutics Ltd. Announces A Collaboration With Wyeth (WYE) On Toll-Like Receptors 2/13/2006 1:06:38 PM
Irish Pharma Start-Up Opsona Therapeutics Ltd. Raises $8.3 Million (EUR6.25 Million) Series A10/19/2005 5:12:51 PM